Introduction: Survivin, an inhibitor of apoptosis, is overexpressed in human urinary
overexpressed in canine urinary bladder TCC.
Materials and Methods: Immunohistochemistry (IHC) with an anti-survivin antibody was performed on archival canine TCC, cystitis, and normal urinary bladder tissues. Reversetranscriptase polymerase chain reaction (PCR) was performed on fresh-frozen tissues (when available). Ki-67, a marker for cell proliferation, was also evaluated by IHC.
Results: Nuclear survivin was present in 27/41 TCC, 12/24 cystitis, and 0/46 normal bladders. Differences between TCC versus normal and cystitis versus normal were significant. Cytoplasmic survivin was present in 7/41 TCC, 2/24 cystitis and 17/46 normal tissues; differences between normal and cystitis were significant. Six of 6 TCC samples, 4/7 cystitis, and 11/22 normal bladder tissues were positive for mRNA, but levels were not significantly different. Tissues with nuclear survivin had a significantly higher Ki-67 score than those without.
Conclusions: As in human tissues, survivin is present in canine TCC. While the presence of survivin in cystitis and normal bladder demonstrates that this is unlikely to be a biomarker for cancer, nuclear survivin is present in TCC and cystitis tissues, but not normal bladder. Nuclear survivin may to play a role in cell proliferation and therefore, may be a target for therapy and prognostic tool for canine bladder tumors.
